Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma

Tumor biopsies may help to reliably distinguish hepatocellular carcinoma (HCC) from other tumors, mostly cholangiocarcinoma as well as to identify the patient populations who most benefit from target-driven HCC treatments, in order to improve the success rate of experimental therapies. Clarifying tu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:World J Gastroenterol
Glavni autori: Rimassa, Lorenza, Reig, Maria, Abbadessa, Giovanni, Peck-Radosavljevic, Markus, Harris, William, Zagonel, Vittorina, Pastorelli, Davide, Rota Caremoli, Elena, Porta, Camillo, Damjanov, Nevena, Patel, Hitendra, Daniele, Bruno, Lamar, Maria, Schwartz, Brian, Goldberg, Terri, Santoro, Armando, Bruix, Jordi
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2017
Teme:
Letters To The Editor
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5385412/
https://ncbi.nlm.nih.gov/pubmed/28428725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i13.2448
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items